rhBMP-2 appears comparable, if not favorable, to ICBG for alveolar cleft repair in pediatric patients, reducing operative time and hospital stays. However, long-term follow-up is needed to confirm efficacy and safety, particularly for other craniofacial reconstruction procedures.
Chou et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: